What Happened?
Cambridge, MA-based Ra-Pharmaceuticals Job-Opening Doug Treco as President and Cheif Executive Officer
About the Company
Ra Pharma combines novel insights into complement and other innate immunity pathways with leadership in macrocycle technology to transform the lives of patients with life threatening disorders.
About the Person
Doug has been the CEO of Ra Pharma, since its inception and serves on the Company`s Board of Directors. In 1988, he co-founded Transkaryotic Therapies Inc. (TKT, acquired in 2005 by Shire plc),a multi-platform biopharmaceutical company developing protein and gene therapy products.
Info Source
Company Announcement
Short Profile